Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer (Site 0002)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer2 trials

Phase

• Phase 1/22 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Merck Sharp & Dohme LLC2 trials

Running trials

• Active, not recruiting

  A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

  NCT06305767· Phase 1/2· Merck Sharp & Dohme LLC· Source

Closed trials

• Completed

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

  NCT06637423· Phase 1/2· Merck Sharp & Dohme LLC· Source